OUR MISSION

TIL Working Group is dedicated to improving outcomes through accelerating the use of TIL Cell Therapy for patients with cancer.

OUR VISION

Our vision is to provide compelling, credible, and relevant education to patient care teams, patients, and advocacy organizations, ensuring safe and appropriate administration of TIL Cell Therapy.

SCIENTIFIC ADVISORY BOARD

OUR MISSION

OUR VISION

SCIENTIFIC ADVISORY BOARD

Omid Hamid, MD

Krishna Komanduri, MD

Rodabe Amaria, MD

Marcus Butler, MD

John Haanen, MD, PhD

Sarah Nikiforow, MD, PhD

Igor Puzanov, MD, MSCI, FACP

Amod Sarnaik, MD

Max Topp, MD

Michael Bishop, MD

Allison Betof Warner, MD, PhD

Adam Schoenfeld, MD